All In Biotech

Drug Trial Radar · NCT00257712

SMART: Somatotrophics, Memory, and Aging Research Trial

GHRH: Cognition in Aging and MCI

Last checked: Nov 20, 2026Latest source record: Dec 19, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 151 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

151

Actual

Start

Feb 2006

Primary completion

Dec 2011

Study completion Dec 2011

Sponsor

Lead sponsor
University of WashingtonAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute on Aging (NIA)
First posted
Nov 23, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 55 years, up to 90 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the SMART study was to better understand whether the body's own production of growth hormone (GH) would improve memory and problem solving ability, or cognitive function. The study was a double blind, placebo-controlled study of the cognitive effects of growth hormone releasing hormone (GHRH) in healthy older men and women and in those with mild cognitive impairment (MCI).

Conditions

  • Aging
  • Mild Cognitive Impairment

Interventions

  • TH9507 human growth hormone releasing hormone (GHRH)Drug

    1mg subcutaneous injection given daily for 20 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in declarative memory, including total recall scores on three tests of memory and on dual task response time (RT), a test of executive function.Time frame: Baseline, 10, 20, and 30 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Washington

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.